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Abstract: Despite recent advances no solution structure for a true G-protein coupled receptor (GPCR) is available
today due to biochemical and spectroscopic problems. Herein we review our attempts to obtain assignments
of GPCRs based on fragments comprising 2-3 transmembrane helices. The fragments are expressed in a
heterologous system, and studied in detergent micelles using solution NMR spectroscopy. We report on the
status of assignments of fragments from the Y4 receptor, a human GPCR. Assignments for the majority of the
backbone resonances are available as well as sidechain assignments for the first two TM helices. Residues of
TM4 are largely invisible. We review technical issues in preparing these samples and in the data analysis. In
addition we developed an approach in which we have grafted the extracellular loops of the Y1 receptor onto
a beta-barrel scaffold derived from the E. coli outer membrane protein OmpA. We could demonstrate that all
loops can be successfully transferred, and that the resulting protein can be successfully refolded. The system is
capable of recognizing the ligands from the neuropeptide Y family.
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Introduction
The structural biology of G-protein
coupled receptors has experienced dynam-
ic progress during the last decade.
[1]
After
the seminal paper from Palczewski on the
structure of bovine rhodopsin in 2000
[2]
a
number of different GPCR structures have
been solved over the last years, several in
both the active and inactive states. This has
tremendously improved our understanding
of the activation process of these receptors
and their underlying structural adaptations.
Recently the first reports on structures of
the complex of a ligand, its GPCR, and the
cognate G-protein appeared.
[3]
All these
structures were solved using X-ray crys-
tallography and, except for the rhodopsin
structures, all GPCRs required stabilizing
mutations to enable crystallization and to
render these receptors sufficiently thermo-
stable for structural studies.
None of the high-resolution structures
of GPCRs were determined using solution
NMR studies so far. The structures of sen-
sory rhodopsin,
[4,5]
a 7 TM integral mem-
brane proteinwith a topology similar to that
of aGPCR, and for proteorhodopsin
[6]
were
recently determined in detergent micelles.
Although both proteins are not coupled to a
G protein, they also represent heptahelical
membrane proteins with architectures very
similar to true GPCRs. Both structures are
well defined, and are considered to present
structures comparable in quality to those
derived from X-ray data. These milestone
achievements indicate that high-quality
NMR structures of heptahelical receptors
are possible, provided that the system un-
der study is sufficiently well behaved.
[7]
In addition sophisticated solid-state NMR
was used to follow structural adaptations
during activation.
[8]
Despite these significant achievements,
no NMR structures of true GPCRs are
presently available, mainly due to a num-
ber of technical difficulties. Expression
and purification of these membrane pro-
teins under conditions that retain activity is
a difficult issue. Another serious problem
is the identification of sample conditions,
under which the protein is sufficiently
stable to allow recording all the required
spectra at elevated temperature and with a
spectral quality that permits assignment of
the spectra. This issue is complicated by
the fact that normally only a small amount
of protein is available impeding screening
of a larger set of conditions. The perspec-
tive of using NMR to investigate dynamics
of GPCRs – information that is difficult
to obtain from crystallographic studies –
merits major investments in methods de-
velopment.
To bypass some of the technical dif-
ficulties when studying entire G-protein
coupled receptors by solution NMR we
are following a divide-and-conquer ap-
proach. Two approaches were followed
by us, schematically depicted in Fig. 1.
In the first we try to dissect the entire re-
ceptors into a set of smaller pieces, in the
following referred to as fragments. These
fragments are studied individually to learn
about their conformational preferences: In
particular, we are interested to see how sta-
bilizing interactions with other parts of the
protein result in conformational changes
in the transmembrane (TM) helices. In ad-
dition these fragments allow us to study
early events in folding of these membrane
proteins since some of the long-range in-
teractions with other parts of the receptor,
e.g. interhelical contacts, are missing and
hence they may provide model systems for
the nascent polypeptide chain. Secondly,
we hope to obtain chemical shift informa-
tion that will be helpful when investigating
the entire receptor. Finally, we hope to im-
prove our understanding of lipid–protein
interactions such that we will be able to
select the best membrane-mimicking en-
vironment for the entire receptor later on.
To be honest: The study of fragments is
heavily under debate since we are investi-
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N-terminal domain and anionic from the li-
gand PP.
[16]
Considering that peptides from
the NPY family associate with the mem-
brane we speculate that a transient inter-
action of the peptides with the N-terminal
domainmight help to transfer them into the
receptor binding-pocket (Fig. 2).
Studies of 2-3 TM Helix Fragments
from the Y4 Receptor
As described above we have expressed
the entire sequence of the Y4 receptor in
the form of 2-3 TM fragments. The pres-
ent status of the backbone assignments of
residues of theY4 receptor as derived from
various fragments is summarized in Fig. 3.
Since we studied the N-terminal domain of
theY4 receptor before, we decided to look
at a construct which comprises this domain
plus TM1 and TM2.
[15]
To be able to solu-
bilize this protein we had to use a mixture
of two detergents. Interestingly, the pro-
tein dramatically alters its solubility in
the two components, dodecylphosphocho-
line (DPC) and 1-palmitoyl-2-hydroxy-
sn-glycero-3-phospho-(1’-rac-glycerol)
(LPPG) after purification by HPLC. A
comparison of the N-terminal domain
quickly revealed that its motional proper-
ties are highly similar to those in the iso-
lated N-terminal domain, indicating that it
is unlikely that this domain is fully folded
gating non-physiological systems. Part of
our justification is based on the two-state
membrane-protein folding model for heli-
cal membrane proteins that was developed
by Popot and Engelman.
[9]
In this model
largely unfolded protein segments parti-
tion into the water–membrane interface
during which they adopt secondary struc-
ture (coupled folding-partitioning). The
helices then fully insert and diffuse in the
membrane until (productive) tertiary con-
tacts are formed. The important difference
to most globular proteins is that fragments
form secondary structure on their own!
The fragmentation approach has therefore
been used previously by other groups to
study interesting domains of GPCRs. The
design of so-called ‘split receptors’ of rho-
dopsin
[10]
and the S. cerevisiae α-factor
receptor Ste2p
[11]
has shown that receptor
fragments can complement each other, re-
storing the functionality of the full-length
receptor. Furthermore, the finding that
fragments derived from the cytoplasmatic
face of rhodopsin were able to competi-
tively inhibit the interaction between rho-
dopsin and its G-protein transducin
[12]
en-
couraged the first structure determination
of such a fragment by NMR.
[13]
Numerous studies by us during the last
years have indicated that fragments cor-
responding to one or more TM helices do
form stable secondary structure.
[14–18]
We
have learned during those studies that the
stability very much depends on the pres-
ence of polar residues in central regions of
the TM helices. The exact structure of the
TM helices in addition depends on tertiary
contacts, and those may be missing in the
segment. Therefore larger proteins com-
prising several TM helices inherently offer
the possibility of stabilization of secondary
structure via inter-helical contacts.
While this approachmay offer some in-
sight into the conformational preferences
of TM helices it is unlikely to be able to re-
port on the loops that connect the TM heli-
ces. In the GPCR structures published over
the last 12 years, loops are sometimes less
well defined. Class A GPCRs also possess
an extracellular N-terminal domain that
usually is unfolded. Large ligands such
as peptide hormones are believed to form
contacts with the loops. To get some in-
sight into ligand interactions with the loops
we have transplanted the loops onto a beta
barrel scaffold.
[19,20]
Compared to the natu-
ral scaffold of a 7TM-bundle, these pro-
teins offer the advantage that they can be
produced inE. coliwith high yields and are
often easily purified. The importance of a
rigid scaffold that will orient the three ex-
tracellular loops of the GPCR in one direc-
tion in space has been highlighted in previ-
ous studies of individual GPCR extracel-
lular loops!
[21]
Using a topological analysis
of the published GPCR crystal structures
and a comparison with published NMR da-
ta of E. coli outer membrane protein A (an
eight-stranded beta-barrel membrane pro-
tein) has revealed that the distances of loop
anchoring points are comparable. The two
approaches for gaining structural informa-
tion on GPCRs are summarized in Fig. 1.
Investigations of the Free
N-Terminal Domains of the Y4
Receptor
The Y receptors contain 40–50 amino
acid-long stretches at the N-terminus in the
extracellular space.
[22]
To probe for their
conformational preferences and their pos-
sible interactions with the ligands, which
are peptide hormones of the NPY family,
we have produced them in
15
N-labelled
form.
[16,17]
[
15
N,
1
H]-HSQC spectra re-
vealed them all to be largely unfolded with
the exception of the N-terminal domain
from theY4 receptor.
[17]
This peptide con-
tains two α-helical stretches at the termini,
separated by a long and flexible loop.
[16]
Interestingly, using surface-plasmon reso-
nance (SPR), we could detect a weak (Kd
of approx. 50 µM) binding to the pancre-
atic polypeptide (PP), which is the peptide
that associates with the Y4 receptor with
the highest affinity. The interactions are
largely mediated via electrostatic interac-
tions, involving cationic residues from the
Fig. 1. Scheme high-
lighting the strate-
gies for obtaining
information on Y
receptors developed
in our laboratory. This
involves the study of
fragments (left) or the
grafting of loops onto
a rigid scaffold (right).
Fig. 2. Scheme de-
scribing the proposed
events taking place
during binding of PP
to the Y4 receptor.
Following association
on the membrane
the ligand diffuses
laterally. Once in vi-
cinity of the receptor
transient association
to the N-terminal
domain might help
to transfer it into the
binding pocket of the
receptor.
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addition the putative helix in the cytosolic
domain is detected, as well as a short am-
phiphatic helix prior to TM1.
in the entire receptor. A representative
[
15
N,
1
H]-TROSY spectrum of NY4-TM1-
TM2 is depicted in Fig. 4. An initial analy-
sis using chemical shifts indicated that the
protein fragment is largely helically struc-
tured. In the meantime we have almost
completely assigned the sidechains of this
protein, and calculated the structure.
[24]
In that structure helices do not extend com-
pletely through the part predicted to be he-
lical using a model of the Y4 receptor that
is based on rhodopsin. Instead, the helices
are interrupted by flexible hinges around
polar or charged residues. Previously, we
had looked at a similar construct from a
yeast GPCR, the Ste2p receptor. In that
fragment the content of polar residues in
internal TM regions was much lower and
secondary structure was present through-
out the putatively helical regions.
[18]
Moreover, we were able to observe tertia-
ry contacts. We believe that the flexibility
seen in Y4-TM1-TM2 is due to the high
number of polar residues in TM1 or TM2
that prevents the helices from fully insert-
ing into the micelle.
[24]
A similar study using TM4-TM5 re-
vealed that most resonances of TM4 were
invisible in the proton–nitrogen corre-
lation map, while signals due to TM5
and the loops could be rapidly assigned.
Absence of signals from TM regions has
been noticed by many others (for a re-
view on NMR of membrane proteins see
the excellent review of Kim et al.
[25]
). The
examples of both sensory rhodopsin
[5]
or
proteorhodopsin,
[6]
for which almost all
signals were found, indicates that this is
not just a problem of size but rather relat-
ed to exchange-broadening. A systematic
study to investigate whether some of the
missing signals could be rescued through
exchange of polar residues in central loca-
tions of the TM helices did not reveal any
improvements of spectra so far. In con-
trast, replacing Trp in the center of TM4
by Phe resulted in line-narrowing, at least
for some residues. Expansions of [
15
N,
1
H]-
HSQC spectra of TM4-TM5 displaying a
reporter signal that is easily recognized in
the spectra (Gly159 from TM4) are depict-
ed in Fig. 5. Obviously, the amide signal
is exchange-broadened in the wild-type
protein but significantly narrowed in the
spectra from the W164F or W164A mu-
tants. Whether mutations are successful
in modifying the protein such that spectra
of sufficient quality can be recorded is un-
clear at the moment. Similarly we worked
on constructs comprising TM6-TM7 plus
the C-terminal (cytosolic) 33 amino acid
domain. Most of the resonances could be
assigned with a few exceptions, this time
mostly related to the repetitive sequence in
some part and not to missing signals.
Chemical shift predictions with the
program TALOS+
[26]
using the assigned
backbone chemical shifts revealed that the
vast majority of residues from the TM re-
gions are predicted to be helical (Fig. 3). In
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Fig. 3. Assignment
status of fragments
from the Y4 recep-
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not be assigned
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spheres to residues
predicted to be heli-
cal or unstructured,
respectively. Helix
termini as well as the
most-conserved posi-
tions are indicated by
numbers, using the
Ballesteros-Weinstein
numbering.
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Fig. 4. [
15
N,
1
H]-
TROSY spectrum
of NY4_TM1-TM2
recorded at 700 MHz
and 320K using a
500 µM sample in 1%
(28 mM) DPC, 6%
(118 mM) LPPG, 40
mM phosphate buffer,
20 mM DTT, pH=6.0.
Peak numbering re-
fers to the sequence
location in the entire
receptor.
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Fig. 5. Expansions of
[
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N,
1
H]-HSQC spec-
tra from TM45 (top),
S171C and S171A
(middle) and W164F
or W164A (bottom)
displaying the cross
peak for G159 that is
part of TM4.
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Some Technical Remarks about the
Work with Fragments
We would like to add a few technical
remarks here: First of all, the biochemistry
of these fragments is far from trivial.While
the entire receptors are certainly very dif-
ficult to produce in large quantities,
[27]
this
is unfortunately also true at least to some
extent for the fragments, although it is
certainly easier. Purification to chemical
homogeneity is another hurdle. Moreover,
we have learned the hard way that careful
characterization of these systems by size-
exclusion chromatography is important
to recognize problems due to aggregation
early on.
Backbone assignments of 2-TM or
even larger constructs definitively re-
quire deuteration of the proteins, other-
wise the sensitivity of the triple-resonance
(TROSY-based) experiments is too low.
Expression levels of the fragments in M9
(labeled) medium is mostly low, and pro-
tein production levels sometimes fall be-
low detectable limits for cultures grown
in deuterated water, as was the case for
TM4-TM5. On that project we have used
the fusion of TM4-TM5 to the N-terminal
domain (NY4_TM4-TM5) to express the
perdeuterated form of the protein, and
later on adapted peaks in the
15
N-TROSY
to the spectrum of TM4-TM5, using the
15
N-resolved NOESY to make sure that
signals were correctly shifted.
Optimization of sample conditions is
another tricky point. This mostly refers
to the correct choice of detergent. Helical
membrane proteins often comprise a deli-
cate balance between protein–protein and
protein–lipid contacts, and are often prone
to aggregation and conformational ex-
change processes. The quality of spectra of
a protein can be dramatically different in
two detergents.
[15,28]
We believe it is fair to
say that the best detergent still needs to be
determined empirically, a process reminis-
cent of the correct choice of buffer condi-
tions in crystallization trials. A really frus-
trating experience in the last years was that
samples that resulted in very promising
spectra on
15
N-labeled protein in proton-
ated detergents transformed into samples
with limited stability and large propensi-
ties for aggregation when either the protein
was deuterated or (often more detrimental)
when perdeuterated detergents were used.
Unfortunately, deuterated detergents are
crucial when using
13
C-resolved NOESY
spectra because otherwise spectra will be
dominated by detergent signals. A prom-
ising new medium for membrane proteins
are the minidisks developed by Slighar
and coworkers.
[29]
While spectra for small
membrane proteins suffer a lot from the in-
creased transverse relaxation in these large
entities (when compared to detergent mi-
celles) for larger membrane proteins such
as entire GPCRs this may not necessarily
be the case any longer. Moreover, stability
of protein has been claimed to be higher in
minidisks allowing spectra to be recorded
at higher temperatures and over more ex-
tended periods of time.
Fragments of GPCRs do not usually
present rigidly folded membrane proteins
with defined tertiary contacts. Moreover,
they may not be uniquely anchored in the
micelles. To characterize such inherently
dynamical systems we have used a strat-
egy that is based on measuring a couple of
NMR parameters to characterize the sys-
tems: i) proton–proton NOEs as done tra-
ditionally for characterizing soluble pro-
teins supplemented by secondary chemical
shifts, ii)
15
N{
1
H}-NOEs to independently
detect flexibility, iii) micelle-integrating
spin labels to probe for the topology of mi-
celle integration, iv) proton–proton NOEs
to detergent moieties or exchange peaks of
amide protons to water. Both can be read-
ily measured in the
15
N-resolved NOESY
spectra, and provide further indirect evi-
dence for micelle integration, v) RDC or
PREs to help establish tertiary contacts.
We need to admit that we still have prob-
lems measuring RDCs in these systems
with the required precision, and that we
also have trouble with attaching the PRE
probes selectively (our systems usually
have multiple Cys sites, and we do not nec-
essarily want to replace all of them).
Grafting of Extracellular Loops
of Y-Receptors onto beta-Barrel
Scaffolds
Replacing the fragile 7TM scaffold of
GPCRs with an inherently more stable and
synthetically more easily accessible scaf-
fold is an interesting option for facilitating
both biochemical and spectroscopic work
on the study of the interaction of the GPCR
extracellular loops and the receptors cog-
nate ligands. So far we have focused in
our studies in this field on the extracellular
loops of the Y receptors. These have been
proposed to present critical interaction
sites with the neurohormone ligands.
[30,31]
It is highly likely that the residues respon-
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Fig. 6. Distance statistics observed in GPCRs and the OmpA scaffold and topology of the four ex-
pressed receptor constructs. a) Histograms of the distances between the anchor points for extra-
cellular loops 1, 2, and 3 as found in a set of 10 GPCR crystal structures and b) for the extracellu-
lar loops in the NMR structures of two OmpA structures and one loop-shortened OmpA construct
(10 conformers each). Average distances between the anchor points for the e1, e2, and e3 loop in
the GPCR structures are indicated by yellow, red and blue bars, respectively. c) Ribbon represen-
tation of rhodopsin with the extracellular loops 1, 2, and 3 colored in yellow, red and blue, respec-
tively. d) Ribbon representation of OmpA with the extracellular loops colored green and the loop
anchor points shown in yellow. e) The four extracellular loops of OmpA were replaced with differ-
ent arrangements of the three Y1 receptor extracellular loops. The fourth OmpA acceptor site was
filled with a minimal turn-inducing sequence (called mini-loop here and depicted schematically
in green). The extracellular loops 1, 2 and 3 of the Y1 receptor are schematically represented by
yellow, red and blue bars, respectively. At the bottom of the panel sequences of the grafted loops
are depicted. Positions shown in red are cysteines in the natural receptor sequences and were
replaced by Ser resiudes in our studies.
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sible for making interactions with the
ligand need to have a suitable topologi-
cal arrangement in order to meet the li-
gand’s structural requirements. Under the
assumption that the extracellular loops,
which form the binding site for the ligand,
are independent from each other a suitable
scaffold must satisfy the following two re-
quirements: i) The points in the scaffold to
which foreign loops are attached (fromnow
on called ‘anchor points’) should match
the geometries observed in the native re-
ceptor and ii) the chemical environment of
these anchor points should mimic the one
found in the foreign receptor. The binding
of many ligands to their cognate GPCRs
in general
[32]
– and of the neurohormones
of the NPY family in particular
[33]
– has
been proposed to be preceded by an initial
generic binding to the membrane bilayer.
In view of the membrane compartment
theory the second requirement indicates
that membrane-embedded scaffolds might
represent more promising candidates as
scaffolds. Due to the lack of high-resolu-
tion structural data on the Y receptors we
instead extracted data on the orientation of
extracellular loop anchor points from the
published GPCR structures. An analysis
of ten crystal structures of four different
GPCRs reveals that the observed distances
between loop attachment points are quite
conserved (Fig. 6a).
The transmembrane domain of the
outer membrane protein A (OmpA) from
E. coli is a eight-stranded transmembrane
beta-barrel protein
[34]
which is structur-
ally well-characterized.
[35,36]
In addition it
has been previously used as a scaffold.
[37]
Furthermore the distances between an-
chor-points in OmpA fall within the range
as required by the GPCRs (Fig. 6b). While
it is impossible to achieve a perfect match,
it can be expected that mismatches may be
partially compensated by structural adap-
tation, and if not, by inserting appropriate
linkers between the grafted loops and the
anchor point.
GPCRs possess three extracellular
loops, while OmpA has four. Theoretically
there are 24 different ways of arranging
three donor loop sequences on the four
acceptor sites of the scaffold. Considering
that not all of these topologies are expedi-
ent it is possible to reduce this number by
eliminating constructs with large distance
mismatches or those in which the loops are
placed in an erroneous sequential arrange-
ment.
We have selected a set of four con-
structs (abbreviated asY1L1,Y1L2,Y1L3,
and Y1L4) in which the arrangement of
the loops is the same as in the GPCRs, and
which are characterized by a low overall
distance mismatch. In theses constructs the
threeY1-receptor extracellular loops (eY1)
were grafted into different OmpA acceptor
positions (Fig. 6e). In order to eliminate any
possible interference of the residues of the
fourth OmpA acceptor site with the graft-
ed eY1, residues from the unused fourth
β-barrel loop were replaced by a minimal
turn-inducing motif of 1-2 amino acids
that were previously shown to not inter-
fere with the folding of the beta-barrel.
[38]
These four constructs could all be ex-
pressed and purified as insoluble inclusion
bodies from E. coli with high yields in the
range of 100 mg per liter of minimal medi-
um culture.
[19]
We could demonstrate that
all proteins in which a single OmpA loop
was replaced by an eY1 loop retained the
β-barrel architecture.
[20]
Indeed, we could
also find suitable conditions for the refold-
ing of the constructs carrying all three eY1
simultaneously. Non-denaturing SDS-
page allowed for easy and rapid screening
of a large number of refolding conditions
on a small scale. Promising reactions were
repeated on a larger scale, and the presence
of a stable tertiary fold assessed by NMR.
This allowed us to find conditions with
>75% refolding efficiencies for all four
constructs.
[19]
Because of the large size and the con-
formational flexibility in the OmpA scaf-
fold
[39]
the quality of the NMR spectra
from these constructs were not sufficient
to allow detailed structural characteriza-
tion. In order to study possible interactions
of these constructs with NPY family neu-
rohormones we thus resorted to chemical
shift mapping using
15
N-labeled neurohor-
mone peptides. We carried out titrations of
theneurohormoneswith refoldedunlabeled
chimeric receptor constructs. Interestingly
only small changes were seen in the neuro-
hormones’ spectra upon addition of two of
the constructs (Y1L1 and Y1L2), whereas
clear changes were observed for the other
two constructs (Y1L3 andY1L4) (Fig. 7a–
7c). Specifically, we observed a gradual
reduction in peak intensity for resonances
towards the C-terminus (Fig. 7d). We attri-
bute this effect to slow exchange between
the unbound and the bound state of the li-
gand, and to the fact that the bound state
is either characterized by many different
substates or further broadened through
exchange. The fact that slow exchange be-
tween bound and unbound forms is pres-
ent indicates that binding to the receptor
constructs is likely in the low micromolar
range.A more precise determination of the
binding constant was unfortunately not yet
possible, mainly due to complications re-
sulting from the competing binding of the
neurohormones to the detergent micelles
into which the receptor constructs were
reconstituted.
The observation that primarily the
C-terminal residues of the neurohormones
are involved in binding to the receptor’s
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d) e)
Fig. 7. Titration of
15
N-labeled porcine NPY (pNPY) with the four receptor constructs. To
15
N-labeled pNPY in 3% dihexanoylphosphatidylcholine (DHPC), 20 mM sodium phosphate pH
6.5, 100 mM NaCl 20 equivalents of the indicated receptor constructs were added. a) The spec-
tra for pNPY in the absence of receptor construct (top left), b) after addition of 20 eq. Y1L2 (top
middle), and c) 20 eq. Y1L3 (top right). d) The decrease in peak intensities upon addition of 20
eq. Y1L3 to pNPY is mapped onto the pNPY sequence. e) STD spectrum of NPY in presence of
20 eq. Y1L3 (upper trace) as well as the reference proton spectrum (lower trace) displaying the
region of amide and aromatic signals.
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extracellular loops is in agreement with
data published by other groups
[40]
and was
further corroborated by us using satura-
tion transfer difference
[41,42]
(STD) experi-
ments
[19]
(Fig. 7e).
The observed affinity for the receptor
model is significantly weaker compared to
the nanomolar dissociation constants ob-
served between the neurohormones and the
natural Y receptors.
[43]
This may indicate
that not all residues responsible for ligand
binding were grafted to the scaffold, e.g.
some residues from the N-terminal do-
main. We are presently investigating to
which extent the N-terminal domain can be
introduced into the remaining (empty) ac-
ceptor loop of the scaffold. Alternatively,
residues from the TM-domain might also
contribute to binding. Including them in
the scaffold is certainly much more chal-
lenging, and requires knowledge of their
chemical nature and position to success-
fully place them inside the barrel. An al-
ternative explanation is that the topology
of the anchor points in the OmpA scaffold
do not allow for an optimal positioning of
the loops relative to each other. We tried
to address this possibility by introducing
flexible glycine-serine linkers in between
the eY1 loops and the anchor points, but
failed to observe increased affinity of these
constructs towards the ligands.
Conclusions
In this paper we have reviewed our
work aimed at obtaining structural data for
G-protein coupled receptors by solution
NMRmethods.We have demonstrated that
we can produce fragments covering the
complete sequence of a human GPCR, the
Y4 receptor. We have seen that chemical
shift information from smaller fragments
can be transferred onto longer constructs
thereby facilitating the assignment pro-
cess a lot. Whether the chemical shift in-
formation can also be transferred onto the
entire receptor needs to be investigated in
future. Of course, preparation of samples
from the entire receptor that yield spectra
of sufficient quality will be of prime im-
portance. To successfully achieve this we
will need to understand more about pro-
tein–lipid interactions and how to recon-
stitute the entire receptors in these systems.
The grafting approach, about which we
also reported in this paper, demonstrated
the synthetic feasibility of such a receptor
model. We are encouraged by the fact that
the receptor model is recognized by the
ligands. However, we need to admit that
the binding affinity is much lower than
for the wild-type receptor underlining the
importance to closely mimic the topology
of the binding site. We would like to con-
clude here that working on GPCR using
solution NMR methods will remain a very
challenging field, but we believe that we
will witness important results in this field
within the next five years.
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